Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Oncologist|July 7, 2021
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational StudyKeigo Chida, Daisuke Kotani, Toshiki Masuishi, et al.
Anticancer Research|October 1, 2021
Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective AnalysisTaiko Nakazawa, Yukiya Narita, Ryosuke Kumanishi, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 3, 2023
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinomaYuki Matsubara, Kazuhiro Toriyama, Shigenori Kadowaki, et al.
The Journal of Pathology|August 7, 2023
Fibrinogen Aα-chain amyloidosis outbreaks in Japanese squirrels (Sciurus lis): a potential disease modelSusumu Iwaide, Nanami Ito, Shiori Ogino, et al.
Therapeutic Advances in Medical Oncology|February 12, 2024
Chronological improvement of survival in patients with advanced gastric cancer over 15 yearsTakatsugu Ogata, Yukiya Narita, Isao Oze, et al.
Anticancer Research|February 29, 2024
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective StudyHiroyuki Kodama, Shigenori Kadowaki, Taiko Nakazawa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal CarcinomaMark G Evans, Harris B Krause, Joanne Xiu, et al.
Therapeutic Advances in Medical Oncology|September 23, 2025
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancerFei Zhang, Izuma Nakayama, Naoya Sakamoto, et al.
Scientific Reports|March 7, 2025
The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinomaKazuhiro Shiraishi, Mao Okada, Shun Yamamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 2, 2024
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancerAmane Jubashi, Izuma Nakayama, Shigehiro Koganemaru, et al.
Pageof 6